Symphony Limited

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, AMBER.BO has a market cap of 283B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while AMBER.BO trades at ₹7,916.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas AMBER.BO's P/E ratio is 172.27. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to AMBER.BO's ROE of +0.06%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to AMBER.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check AMBER.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, AMBER.NS has a market cap of 282.9B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while AMBER.NS trades at ₹7,929.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas AMBER.NS's P/E ratio is 171.96. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to AMBER.NS's ROE of +0.06%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to AMBER.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check AMBER.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, CROMPTON.NS has a market cap of 169.5B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while CROMPTON.NS trades at ₹262.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas CROMPTON.NS's P/E ratio is 36.72. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to CROMPTON.NS's ROE of +0.13%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to CROMPTON.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check CROMPTON.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, CROMPTON.BO has a market cap of 169.5B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while CROMPTON.BO trades at ₹262.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas CROMPTON.BO's P/E ratio is 36.71. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to CROMPTON.BO's ROE of +0.13%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to CROMPTON.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check CROMPTON.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, CENTURYPLY.NS has a market cap of 166.6B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while CENTURYPLY.NS trades at ₹754.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas CENTURYPLY.NS's P/E ratio is 70.14. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to CENTURYPLY.NS's ROE of +0.10%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to CENTURYPLY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check CENTURYPLY.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, WHIRLPOOL.BO has a market cap of 116.7B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while WHIRLPOOL.BO trades at ₹901.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas WHIRLPOOL.BO's P/E ratio is 33.31. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to WHIRLPOOL.BO's ROE of +0.08%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to WHIRLPOOL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check WHIRLPOOL.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, WHIRLPOOL.NS has a market cap of 116.7B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while WHIRLPOOL.NS trades at ₹904.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas WHIRLPOOL.NS's P/E ratio is 35.07. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to WHIRLPOOL.NS's ROE of +0.08%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to WHIRLPOOL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check WHIRLPOOL.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, EUREKAFORB.BO has a market cap of 94.1B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while EUREKAFORB.BO trades at ₹493.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas EUREKAFORB.BO's P/E ratio is 58.71. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to EUREKAFORB.BO's ROE of +0.04%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to EUREKAFORB.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check EUREKAFORB.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, EUREKAFORB.NS has a market cap of 93.8B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while EUREKAFORB.NS trades at ₹492.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas EUREKAFORB.NS's P/E ratio is 58.54. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to EUREKAFORB.NS's ROE of +0.04%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to EUREKAFORB.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check EUREKAFORB.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, CELLO.NS has a market cap of 91.4B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while CELLO.NS trades at ₹427.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas CELLO.NS's P/E ratio is 29.59. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to CELLO.NS's ROE of +0.14%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to CELLO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check CELLO.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, CELLO.BO has a market cap of 91.4B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while CELLO.BO trades at ₹427.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas CELLO.BO's P/E ratio is 29.62. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to CELLO.BO's ROE of +0.14%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to CELLO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check CELLO.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, TTKPRESTIG.BO has a market cap of 72.8B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while TTKPRESTIG.BO trades at ₹539.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas TTKPRESTIG.BO's P/E ratio is 87.25. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to TTKPRESTIG.BO's ROE of +0.04%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to TTKPRESTIG.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check TTKPRESTIG.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, TTKPRESTIG.NS has a market cap of 72.7B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while TTKPRESTIG.NS trades at ₹540.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas TTKPRESTIG.NS's P/E ratio is 87.19. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to TTKPRESTIG.NS's ROE of +0.04%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to TTKPRESTIG.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check TTKPRESTIG.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, AVL.BO has a market cap of 62.2B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while AVL.BO trades at ₹481.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas AVL.BO's P/E ratio is 56.20. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to AVL.BO's ROE of +0.19%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to AVL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check AVL.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, GREENLAM.NS has a market cap of 60.8B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while GREENLAM.NS trades at ₹236.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas GREENLAM.NS's P/E ratio is 355.76. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to GREENLAM.NS's ROE of +0.02%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to GREENLAM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check GREENLAM.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, GREENLAM.BO has a market cap of 60.4B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while GREENLAM.BO trades at ₹238.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas GREENLAM.BO's P/E ratio is 353.36. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to GREENLAM.BO's ROE of +0.02%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to GREENLAM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check GREENLAM.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, SFL.BO has a market cap of 60.2B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while SFL.BO trades at ₹555.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas SFL.BO's P/E ratio is 68.25. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to SFL.BO's ROE of +0.03%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to SFL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check SFL.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, SFL.NS has a market cap of 60.1B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while SFL.NS trades at ₹555.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas SFL.NS's P/E ratio is 68.01. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to SFL.NS's ROE of +0.03%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to SFL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check SFL.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, SYMPHONY.NS has a market cap of 57.4B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while SYMPHONY.NS trades at ₹839.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas SYMPHONY.NS's P/E ratio is 33.93. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to SYMPHONY.NS's ROE of +0.21%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to SYMPHONY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check SYMPHONY.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, IFBIND.NS has a market cap of 44.9B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while IFBIND.NS trades at ₹1,121.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas IFBIND.NS's P/E ratio is 37.48. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to IFBIND.NS's ROE of +0.13%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to IFBIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check IFBIND.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, IFBIND.BO has a market cap of 44.8B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while IFBIND.BO trades at ₹1,122.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas IFBIND.BO's P/E ratio is 37.37. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to IFBIND.BO's ROE of +0.13%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to IFBIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check IFBIND.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, BAJAJELEC.NS has a market cap of 42.5B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while BAJAJELEC.NS trades at ₹370.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas BAJAJELEC.NS's P/E ratio is 119.68. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to BAJAJELEC.NS's ROE of +0.02%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to BAJAJELEC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check BAJAJELEC.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, BAJAJELEC.BO has a market cap of 42.4B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while BAJAJELEC.BO trades at ₹370.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas BAJAJELEC.BO's P/E ratio is 39.37. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to BAJAJELEC.BO's ROE of +0.02%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to BAJAJELEC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check BAJAJELEC.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, JCHAC.NS has a market cap of 38.9B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while JCHAC.NS trades at ₹1,432.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas JCHAC.NS's P/E ratio is 138.91. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to JCHAC.NS's ROE of +0.02%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to JCHAC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check JCHAC.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, JCHAC.BO has a market cap of 38.8B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while JCHAC.BO trades at ₹1,427.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas JCHAC.BO's P/E ratio is 137.83. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to JCHAC.BO's ROE of +0.05%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to JCHAC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check JCHAC.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, BOSCH-HCIL.BO has a market cap of 38.3B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while BOSCH-HCIL.BO trades at ₹1,370.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas BOSCH-HCIL.BO's P/E ratio is 309.44. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to BOSCH-HCIL.BO's ROE of +0.05%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to BOSCH-HCIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check BOSCH-HCIL.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, BOSCH-HCIL.NS has a market cap of 38.2B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while BOSCH-HCIL.NS trades at ₹1,378.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas BOSCH-HCIL.NS's P/E ratio is 315.13. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to BOSCH-HCIL.NS's ROE of +0.05%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to BOSCH-HCIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check BOSCH-HCIL.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, STYLAMIND.BO has a market cap of 37.5B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while STYLAMIND.BO trades at ₹2,212.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas STYLAMIND.BO's P/E ratio is 26.58. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to STYLAMIND.BO's ROE of +0.21%. Regarding short-term risk, SYMPHONY.BO is more volatile compared to STYLAMIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SYMPHONY.BO.Check STYLAMIND.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, STYLAMIND.NS has a market cap of 37.5B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while STYLAMIND.NS trades at ₹2,216.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas STYLAMIND.NS's P/E ratio is 26.57. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to STYLAMIND.NS's ROE of +0.21%. Regarding short-term risk, SYMPHONY.BO is more volatile compared to STYLAMIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SYMPHONY.BO.Check STYLAMIND.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, ORIENTELEC.BO has a market cap of 37.4B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while ORIENTELEC.BO trades at ₹174.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas ORIENTELEC.BO's P/E ratio is 43.03. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to ORIENTELEC.BO's ROE of +0.13%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to ORIENTELEC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check ORIENTELEC.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, ORIENTELEC.NS has a market cap of 37.3B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while ORIENTELEC.NS trades at ₹174.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas ORIENTELEC.NS's P/E ratio is 42.89. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to ORIENTELEC.NS's ROE of +0.13%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to ORIENTELEC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check ORIENTELEC.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, BOROLTD.NS has a market cap of 28.8B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while BOROLTD.NS trades at ₹245.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas BOROLTD.NS's P/E ratio is 38.35. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to BOROLTD.NS's ROE of +0.09%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to BOROLTD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check BOROLTD.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, BOROLTD.BO has a market cap of 28.8B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while BOROLTD.BO trades at ₹245.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas BOROLTD.BO's P/E ratio is 38.33. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to BOROLTD.BO's ROE of +0.09%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to BOROLTD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check BOROLTD.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, CARYSIL.NS has a market cap of 25.9B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while CARYSIL.NS trades at ₹918.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas CARYSIL.NS's P/E ratio is 28.96. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to CARYSIL.NS's ROE of +0.17%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to CARYSIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check CARYSIL.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, CARYSIL.BO has a market cap of 25.8B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while CARYSIL.BO trades at ₹917.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas CARYSIL.BO's P/E ratio is 28.73. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to CARYSIL.BO's ROE of +0.17%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to CARYSIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check CARYSIL.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, GREENPANEL.NS has a market cap of 25.3B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while GREENPANEL.NS trades at ₹209.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas GREENPANEL.NS's P/E ratio is -2296.00. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to GREENPANEL.NS's ROE of -0.00%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to GREENPANEL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check GREENPANEL.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, LAOPALA.BO has a market cap of 22.5B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while LAOPALA.BO trades at ₹208.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas LAOPALA.BO's P/E ratio is 22.12. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to LAOPALA.BO's ROE of +0.12%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to LAOPALA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check LAOPALA.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, LAOPALA.NS has a market cap of 22.5B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while LAOPALA.NS trades at ₹208.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas LAOPALA.NS's P/E ratio is 22.10. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to LAOPALA.NS's ROE of +0.12%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to LAOPALA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check LAOPALA.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, NILKAMAL.NS has a market cap of 20.8B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while NILKAMAL.NS trades at ₹1,395.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas NILKAMAL.NS's P/E ratio is 19.20. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to NILKAMAL.NS's ROE of +0.07%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to NILKAMAL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check NILKAMAL.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, NILKAMAL.BO has a market cap of 20.7B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while NILKAMAL.BO trades at ₹1,393.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas NILKAMAL.BO's P/E ratio is 19.13. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to NILKAMAL.BO's ROE of +0.07%. Regarding short-term risk, SYMPHONY.BO is more volatile compared to NILKAMAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SYMPHONY.BO.Check NILKAMAL.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, HINDWAREAP.BO has a market cap of 19.6B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while HINDWAREAP.BO trades at ₹228.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas HINDWAREAP.BO's P/E ratio is -34.79. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to HINDWAREAP.BO's ROE of -0.07%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to HINDWAREAP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check HINDWAREAP.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, HINDWAREAP.NS has a market cap of 19.5B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while HINDWAREAP.NS trades at ₹228.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas HINDWAREAP.NS's P/E ratio is -34.65. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to HINDWAREAP.NS's ROE of -0.07%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to HINDWAREAP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check HINDWAREAP.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, WEL.NS has a market cap of 18.7B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while WEL.NS trades at ₹141.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas WEL.NS's P/E ratio is 103.96. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to WEL.NS's ROE of +0.14%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to WEL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check WEL.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, WEL.BO has a market cap of 18.6B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while WEL.BO trades at ₹141.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas WEL.BO's P/E ratio is 103.07. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to WEL.BO's ROE of +0.11%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to WEL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check WEL.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, STOVEKRAFT.NS has a market cap of 16.2B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while STOVEKRAFT.NS trades at ₹483.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas STOVEKRAFT.NS's P/E ratio is 43.41. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to STOVEKRAFT.NS's ROE of +0.08%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to STOVEKRAFT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check STOVEKRAFT.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, STOVEKRAFT.BO has a market cap of 16.1B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while STOVEKRAFT.BO trades at ₹482.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas STOVEKRAFT.BO's P/E ratio is 43.06. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to STOVEKRAFT.BO's ROE of +0.08%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to STOVEKRAFT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check STOVEKRAFT.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, BUTTERFLY.NS has a market cap of 10.7B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while BUTTERFLY.NS trades at ₹600.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas BUTTERFLY.NS's P/E ratio is 24.87. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to BUTTERFLY.NS's ROE of +0.13%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to BUTTERFLY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check BUTTERFLY.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, BUTTERFLY.BO has a market cap of 10.7B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while BUTTERFLY.BO trades at ₹600.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas BUTTERFLY.BO's P/E ratio is 24.83. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to BUTTERFLY.BO's ROE of +0.13%. Regarding short-term risk, SYMPHONY.BO is more volatile compared to BUTTERFLY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SYMPHONY.BO.Check BUTTERFLY.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, SAINTGOBAIN.BO has a market cap of 10.3B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while SAINTGOBAIN.BO trades at ₹113.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas SAINTGOBAIN.BO's P/E ratio is 28.70. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to SAINTGOBAIN.BO's ROE of +0.19%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to SAINTGOBAIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check SAINTGOBAIN.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, ROBU.BO has a market cap of 9.6B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while ROBU.BO trades at ₹999.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas ROBU.BO's P/E ratio is 46.45. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to ROBU.BO's ROE of +0.29%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to ROBU.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check ROBU.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, STANLEY.NS has a market cap of 9.3B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while STANLEY.NS trades at ₹167.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas STANLEY.NS's P/E ratio is 38.94. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to STANLEY.NS's ROE of +0.05%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to STANLEY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check STANLEY.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, MIRCELECTR.BO has a market cap of 8.4B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while MIRCELECTR.BO trades at ₹28.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas MIRCELECTR.BO's P/E ratio is -41.71. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to MIRCELECTR.BO's ROE of -0.19%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to MIRCELECTR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check MIRCELECTR.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, MIRCELECTR.NS has a market cap of 7.9B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while MIRCELECTR.NS trades at ₹28.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas MIRCELECTR.NS's P/E ratio is -32.51. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to MIRCELECTR.NS's ROE of -0.19%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to MIRCELECTR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check MIRCELECTR.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, RUSHIL.NS has a market cap of 5.3B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while RUSHIL.NS trades at ₹18.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas RUSHIL.NS's P/E ratio is 55.09. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to RUSHIL.NS's ROE of +0.02%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to RUSHIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check RUSHIL.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, RUSHIL.BO has a market cap of 5.3B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while RUSHIL.BO trades at ₹18.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas RUSHIL.BO's P/E ratio is 54.85. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to RUSHIL.BO's ROE of +0.02%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to RUSHIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check RUSHIL.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, WIMPLAST.BO has a market cap of 4.7B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while WIMPLAST.BO trades at ₹390.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas WIMPLAST.BO's P/E ratio is 7.77. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to WIMPLAST.BO's ROE of +0.11%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to WIMPLAST.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check WIMPLAST.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, SINGER.BO has a market cap of 4.6B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while SINGER.BO trades at ₹72.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas SINGER.BO's P/E ratio is 64.18. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to SINGER.BO's ROE of +0.07%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to SINGER.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check SINGER.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, FOCUS.NS has a market cap of 4.4B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while FOCUS.NS trades at ₹65.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas FOCUS.NS's P/E ratio is 92.17. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to FOCUS.NS's ROE of +0.03%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to FOCUS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check FOCUS.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, BELLACASA.BO has a market cap of 3.9B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while BELLACASA.BO trades at ₹277.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas BELLACASA.BO's P/E ratio is 19.39. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to BELLACASA.BO's ROE of +0.15%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to BELLACASA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check BELLACASA.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, SPITZE.BO has a market cap of 3.2B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while SPITZE.BO trades at ₹199.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas SPITZE.BO's P/E ratio is 51.20. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to SPITZE.BO's ROE of +0.17%. Regarding short-term risk, SYMPHONY.BO is more volatile compared to SPITZE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SYMPHONY.BO.Check SPITZE.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, BHATIA.BO has a market cap of 2.9B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while BHATIA.BO trades at ₹21.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas BHATIA.BO's P/E ratio is 22.40. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to BHATIA.BO's ROE of +0.17%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to BHATIA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check BHATIA.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, VIDEOIND.NS has a market cap of 2.5B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while VIDEOIND.NS trades at ₹7.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas VIDEOIND.NS's P/E ratio is -0.03. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to VIDEOIND.NS's ROE of +0.28%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to VIDEOIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check VIDEOIND.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, INFLAME.BO has a market cap of 2.3B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while INFLAME.BO trades at ₹301.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas INFLAME.BO's P/E ratio is 39.05. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to INFLAME.BO's ROE of +0.10%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to INFLAME.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check INFLAME.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, PILITA.BO has a market cap of 2B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while PILITA.BO trades at ₹8.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas PILITA.BO's P/E ratio is 47.22. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to PILITA.BO's ROE of +0.06%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to PILITA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check PILITA.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, PILITA.NS has a market cap of 2B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while PILITA.NS trades at ₹8.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas PILITA.NS's P/E ratio is 46.78. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to PILITA.NS's ROE of +0.06%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to PILITA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check PILITA.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, SONAMLTD.NS has a market cap of 1.9B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while SONAMLTD.NS trades at ₹48.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas SONAMLTD.NS's P/E ratio is 30.33. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to SONAMLTD.NS's ROE of +0.11%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to SONAMLTD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check SONAMLTD.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, AVROIND.BO has a market cap of 1.7B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while AVROIND.BO trades at ₹124.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas AVROIND.BO's P/E ratio is 45.05. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to AVROIND.BO's ROE of +0.06%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to AVROIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check AVROIND.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, AVROIND.NS has a market cap of 1.7B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while AVROIND.NS trades at ₹122.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas AVROIND.NS's P/E ratio is 43.95. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to AVROIND.NS's ROE of +0.06%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to AVROIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check AVROIND.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, SONAMCLOCK.NS has a market cap of 1.6B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while SONAMCLOCK.NS trades at ₹81.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas SONAMCLOCK.NS's P/E ratio is 40.88. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to SONAMCLOCK.NS's ROE of +0.08%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to SONAMCLOCK.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check SONAMCLOCK.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, AIROLAM.NS has a market cap of 1.4B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while AIROLAM.NS trades at ₹92.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas AIROLAM.NS's P/E ratio is 51.28. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to AIROLAM.NS's ROE of +0.11%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to AIROLAM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check AIROLAM.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, PRIMAPLA.BO has a market cap of 1.3B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while PRIMAPLA.BO trades at ₹116.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas PRIMAPLA.BO's P/E ratio is 7.12. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to PRIMAPLA.BO's ROE of +0.10%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to PRIMAPLA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check PRIMAPLA.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, TEXELIN.BO has a market cap of 1.1B. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while TEXELIN.BO trades at ₹83.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas TEXELIN.BO's P/E ratio is 5.07. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to TEXELIN.BO's ROE of +0.31%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to TEXELIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check TEXELIN.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, FOCUS.BO has a market cap of 909.9M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while FOCUS.BO trades at ₹125.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas FOCUS.BO's P/E ratio is 77.64. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to FOCUS.BO's ROE of +0.03%. Regarding short-term risk, SYMPHONY.BO is more volatile compared to FOCUS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SYMPHONY.BO.Check FOCUS.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, PRITI.NS has a market cap of 630.5M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while PRITI.NS trades at ₹46.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas PRITI.NS's P/E ratio is 17.89. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to PRITI.NS's ROE of +0.02%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to PRITI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check PRITI.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, SACHEMT.BO has a market cap of 488.8M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while SACHEMT.BO trades at ₹3.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas SACHEMT.BO's P/E ratio is 21.72. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to SACHEMT.BO's ROE of +0.04%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to SACHEMT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check SACHEMT.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, KHAITANLTD.BO has a market cap of 450.3M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while KHAITANLTD.BO trades at ₹93.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas KHAITANLTD.BO's P/E ratio is 6.85. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to KHAITANLTD.BO's ROE of +0.25%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to KHAITANLTD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check KHAITANLTD.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, KHAITANLTD.NS has a market cap of 443.9M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while KHAITANLTD.NS trades at ₹91.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas KHAITANLTD.NS's P/E ratio is 6.76. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to KHAITANLTD.NS's ROE of +0.25%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to KHAITANLTD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check KHAITANLTD.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, ADL.BO has a market cap of 422.8M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while ADL.BO trades at ₹74.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas ADL.BO's P/E ratio is 3797.50. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to ADL.BO's ROE of +0.00%. Regarding short-term risk, SYMPHONY.BO is more volatile compared to ADL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SYMPHONY.BO.Check ADL.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, ADL.NS has a market cap of 392.2M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while ADL.NS trades at ₹73.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas ADL.NS's P/E ratio is 3523.00. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to ADL.NS's ROE of +0.00%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to ADL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check ADL.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, GORANIN.BO has a market cap of 319.3M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while GORANIN.BO trades at ₹58.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas GORANIN.BO's P/E ratio is 27.07. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to GORANIN.BO's ROE of +0.07%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to GORANIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check GORANIN.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, TIRUFOAM.BO has a market cap of 315.1M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while TIRUFOAM.BO trades at ₹71.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas TIRUFOAM.BO's P/E ratio is 14.39. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to TIRUFOAM.BO's ROE of +0.06%. Regarding short-term risk, SYMPHONY.BO is more volatile compared to TIRUFOAM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SYMPHONY.BO.Check TIRUFOAM.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, GUJRAFIA.BO has a market cap of 300.5M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while GUJRAFIA.BO trades at ₹55.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas GUJRAFIA.BO's P/E ratio is 94.24. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to GUJRAFIA.BO's ROE of +0.02%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to GUJRAFIA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check GUJRAFIA.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, MILEFUR.BO has a market cap of 278M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while MILEFUR.BO trades at ₹29.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas MILEFUR.BO's P/E ratio is -74.75. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to MILEFUR.BO's ROE of -0.02%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to MILEFUR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check MILEFUR.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, JAIMATAG.BO has a market cap of 230M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while JAIMATAG.BO trades at ₹1.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas JAIMATAG.BO's P/E ratio is -32.86. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to JAIMATAG.BO's ROE of -0.31%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to JAIMATAG.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check JAIMATAG.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, JAIPAN.BO has a market cap of 157.6M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while JAIPAN.BO trades at ₹25.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas JAIPAN.BO's P/E ratio is 29.03. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to JAIPAN.BO's ROE of +0.60%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to JAIPAN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check JAIPAN.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, APIL.BO has a market cap of 135.8M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while APIL.BO trades at ₹41.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas APIL.BO's P/E ratio is -14.26. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to APIL.BO's ROE of -0.14%. Regarding short-term risk, SYMPHONY.BO is more volatile compared to APIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SYMPHONY.BO.Check APIL.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, SEASONST.BO has a market cap of 134.8M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while SEASONST.BO trades at ₹17.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas SEASONST.BO's P/E ratio is -180.00. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to SEASONST.BO's ROE of -0.00%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to SEASONST.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check SEASONST.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, KAHAN.BO has a market cap of 133.3M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while KAHAN.BO trades at ₹50.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas KAHAN.BO's P/E ratio is 11.56. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to KAHAN.BO's ROE of +0.09%. Regarding short-term risk, SYMPHONY.BO is more volatile compared to KAHAN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SYMPHONY.BO.Check KAHAN.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, PHOTOQUP.BO has a market cap of 101.4M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while PHOTOQUP.BO trades at ₹16.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas PHOTOQUP.BO's P/E ratio is 73.43. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to PHOTOQUP.BO's ROE of +0.02%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to PHOTOQUP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check PHOTOQUP.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, MPL.BO has a market cap of 92.5M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while MPL.BO trades at ₹7.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas MPL.BO's P/E ratio is -20.00. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to MPL.BO's ROE of +0.13%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to MPL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check MPL.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, KUWERIN.BO has a market cap of 75.2M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while KUWERIN.BO trades at ₹8.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas KUWERIN.BO's P/E ratio is 14.54. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to KUWERIN.BO's ROE of +0.00%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to KUWERIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check KUWERIN.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, GOLCA.BO has a market cap of 65.6M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while GOLCA.BO trades at ₹10.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas GOLCA.BO's P/E ratio is -43.91. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to GOLCA.BO's ROE of +1.21%. Regarding short-term risk, SYMPHONY.BO is more volatile compared to GOLCA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SYMPHONY.BO.Check GOLCA.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, JIKIND.NS has a market cap of 47.2M. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while JIKIND.NS trades at ₹0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas JIKIND.NS's P/E ratio is -21.67. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to JIKIND.NS's ROE of +0.00%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to JIKIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check JIKIND.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, WFL.NS has a market cap of 0. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while WFL.NS trades at ₹269.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas WFL.NS's P/E ratio is N/A. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to WFL.NS's ROE of +0.11%. Regarding short-term risk, SYMPHONY.BO is more volatile compared to WFL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SYMPHONY.BO.Check WFL.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, EUREKAFORBE.BO has a market cap of 0. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while EUREKAFORBE.BO trades at ₹502.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas EUREKAFORBE.BO's P/E ratio is N/A. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to EUREKAFORBE.BO's ROE of +0.02%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to EUREKAFORBE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check EUREKAFORBE.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, ELIL.BO has a market cap of 0. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while ELIL.BO trades at ₹202.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas ELIL.BO's P/E ratio is N/A. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to ELIL.BO's ROE of N/A. Regarding short-term risk, SYMPHONY.BO is less volatile compared to ELIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check ELIL.BO's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, SHIL.NS has a market cap of 0. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while SHIL.NS trades at ₹272.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas SHIL.NS's P/E ratio is 9.77. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to SHIL.NS's ROE of +0.10%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to SHIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check SHIL.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, ACRYSIL.NS has a market cap of 0. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while ACRYSIL.NS trades at ₹494.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas ACRYSIL.NS's P/E ratio is 21.59. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to ACRYSIL.NS's ROE of +0.19%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to ACRYSIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check ACRYSIL.NS's competition here

SYMPHONY.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SYMPHONY.BO stands at 57.4B. In comparison, HSIL.NS has a market cap of 0. Regarding current trading prices, SYMPHONY.BO is priced at ₹839.00, while HSIL.NS trades at ₹298.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SYMPHONY.BO currently has a P/E ratio of 33.91, whereas HSIL.NS's P/E ratio is 18.70. In terms of profitability, SYMPHONY.BO's ROE is +0.21%, compared to HSIL.NS's ROE of +0.09%. Regarding short-term risk, SYMPHONY.BO is less volatile compared to HSIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SYMPHONY.BO.Check HSIL.NS's competition here